Global Crohn s Disease Drug Market Status and Outlook 2018-2025

August 2018 | 155 pages | ID: G46142394F5EN
99Strategy

Abstracts

REPORT SNAPSHOT

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1:
Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2:
Upstream (Raw Materials/Components) & Manufacturing (Procurement Methods & Channels and Cost), Major Regional Production Overview and Trade Flow
Part 3:
Product Segment Overview and Market Status
Part 4:
Application/End-User Segment Overview and Market Status
Part 5:
Region Segment Overview and Market Status
Part 6:
Product & Application Segment Production & Demand by Region
Part 7:
Market Forecast by Product, Application & Region
Part 8:
Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9:
Market Competition and Environment for New Entrants
Part 10:
Conclusion

Market Segment as follows:

Key Companies

• AbbVie
• Janssen Biotech
• UCB
• Amgen
• Tillotts Pharma
• Takeda Pharmaceuticals

Market by Type

• Aminosalicylates (5-ASA)
• Corticosteroids
• Immunomodulators
• Antibiotics

Market by Application

• Achieving Remission (The Absence Of Symptoms)
• Maintaining Remission (Prevention Of Flare-Ups)
• Pediatric Crohn'S Disease

Contents

PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Crohn s Disease Drug Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 Aminosalicylates (5-ASA)
  3.1.2 Corticosteroids
  3.1.3 Immunomodulators
  3.1.4 Antibiotics
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Achieving Remission (The Absence Of Symptoms)
  4.1.2 Maintaining Remission (Prevention Of Flare-Ups)
  4.1.3 Pediatric Crohn'S Disease
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sultan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 Aminosalicylates (5-ASA) Production by Region
    6.1.1.2 Corticosteroids Production by Region
    6.1.1.3 Immunomodulators Production by Region
    6.1.1.4 Antibiotics Production by Region
  6.1.2 Production by Application
    6.1.2.1 Achieving Remission (The Absence Of Symptoms) Production by Region
    6.1.2.2 Maintaining Remission (Prevention Of Flare-Ups) Production by Region
    6.1.2.3 Pediatric Crohn'S Disease Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 Aminosalicylates (5-ASA) Demand by Region
    6.2.1.2 Corticosteroids Demand by Region
    6.2.1.3 Immunomodulators Demand by Region
    6.2.1.4 Antibiotics Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Achieving Remission (The Absence Of Symptoms) Demand by Region
    6.2.2.2 Maintaining Remission (Prevention Of Flare-Ups) Demand by Region
    6.2.2.3 Pediatric Crohn'S Disease Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 AbbVie
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Janssen Biotech
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 UCB
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 Amgen
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 Tillotts Pharma
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation
8.6 Takeda Pharmaceuticals
  8.6.1 Company Information
  8.6.2 Products & Services
  8.6.3 Business Operation

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

List Of Tables

LIST OF TABLES

Table Crohn s Disease Drug Industry Dynamics & Regulations List
Table Global Crohn s Disease Drug Sales Revenue, Cost and Margin, 2015-2018E
Table Global Crohn s Disease Drug Market Status by Type 2015-2018E, in USD Million
Table Global Crohn s Disease Drug Market Status by Application 2015-2018E, in USD Million
Table Global Crohn s Disease Drug Market Status by Application 2015-2018E, in Volume
Table Global Crohn s Disease Drug Market by Region 2015-2018E, in USD Million
Table Global Crohn s Disease Drug Market Share by Region in 2018, in USD Million
Table Global Crohn s Disease Drug Market by Region 2015-2018E, in Volume
Table Global Crohn s Disease Drug Market Share by Region in 2018, in Volume
Table Aminosalicylates (5-ASA) Production Value by Region 2015-2018E, in USD Million
Table Aminosalicylates (5-ASA) Production Volume by Region 2015-2018E, in Volume
Table Corticosteroids Production Value by Region 2015-2018E, in USD Million
Table Corticosteroids Production Volume by Region 2015-2018E, in Volume
Table Immunomodulators Production Value by Region 2015-2018E, in USD Million
Table Immunomodulators Production Volume by Region 2015-2018E, in Volume
Table Antibiotics Production Value by Region 2015-2018E, in USD Million
Table Antibiotics Production Volume by Region 2015-2018E, in Volume
Table Achieving Remission (The Absence Of Symptoms) Production Value by Region 2015-2018E, in USD Million
Table Achieving Remission (The Absence Of Symptoms) Production Volume by Region 2015-2018E, in Volume
Table Maintaining Remission (Prevention Of Flare-Ups) Production Value by Region 2015-2018E, in USD Million
Table Maintaining Remission (Prevention Of Flare-Ups) Production Volume by Region 2015-2018E, in Volume
Table Pediatric Crohn'S Disease Production Value by Region 2015-2018E, in USD Million
Table Pediatric Crohn'S Disease Production Volume by Region 2015-2018E, in Volume
Table Aminosalicylates (5-ASA) Market Size by Region 2015-2018E, in USD Million
Table Aminosalicylates (5-ASA) Market Size by Region 2015-2018E, in Volume
Table Corticosteroids Market Size by Region 2015-2018E, in USD Million
Table Corticosteroids Market Size by Region 2015-2018E, in Volume
Table Immunomodulators Market Size by Region 2015-2018E, in USD Million
Table Immunomodulators Market Size by Region 2015-2018E, in Volume
Table Antibiotics Market Size by Region 2015-2018E, in USD Million
Table Antibiotics Market Size by Region 2015-2018E, in Volume
Table Achieving Remission (The Absence Of Symptoms) Market Size by Region 2015-2018E, in USD Million
Table Achieving Remission (The Absence Of Symptoms) Market Size by Region 2015-2018E, in Volume
Table Maintaining Remission (Prevention Of Flare-Ups) Market Size by Region 2015-2018E, in USD Million
Table Maintaining Remission (Prevention Of Flare-Ups) Market Size by Region 2015-2018E, in Volume
Table Pediatric Crohn'S Disease Market Size by Region 2015-2018E, in USD Million
Table Pediatric Crohn'S Disease Market Size by Region 2015-2018E, in Volume
Table GlobalCrohn s Disease Drug Forecast by Type 2019F-2025F, in USD Million
Table Crohn s Disease Drug Forecast by Type 2019F-2025F, in Volume
Table Crohn s Disease Drug Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Crohn s Disease Drug Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Crohn s Disease Drug Market Forecast by Region 2019F-2025F, in USD Million
Table Crohn s Disease Drug Market Forecast by Region 2019F-2025F, in Volume
Table AbbVie Information
Table Crohn s Disease Drug Sales, Cost, Margin of AbbVie
Table Janssen Biotech Information
Table Crohn s Disease Drug Sales, Cost, Margin of Janssen Biotech
Table UCB Information
Table Crohn s Disease Drug Sales, Cost, Margin of UCB
Table Amgen Information
Table Crohn s Disease Drug Sales, Cost, Margin of Amgen
Table Tillotts Pharma Information
Table Crohn s Disease Drug Sales, Cost, Margin of Tillotts Pharma
Table Takeda Pharmaceuticals Information
Table Crohn s Disease Drug Sales, Cost, Margin of Takeda Pharmaceuticals
Table Global Crohn s Disease Drug Sales Revenue by Company 2015-2017, in USD Million
Table Global Crohn s Disease Drug Sales Volume by Company 2015-2017, in Volume
Table Global Crohn s Disease Drug Sales Volume by Company in 2018, in Volume

List Of Figures

LIST OF FIGURES

Figure Crohn s Disease Drug Picture
Figure Crohn s Disease Drug Industry Chain Diagram
Figure Global Crohn s Disease Drug Sales Revenue 2015-2018E, in USD Million
Figure Global Crohn s Disease Drug Sales Volume 2015-2018E, in Volume
Figure Global Crohn s Disease Drug Market Status by Type 2015-2018E, in Volume
Figure North America Crohn s Disease Drug Market Size and Growth 2015-2018E, in USD Million
Figure North America Crohn s Disease Drug Market Size and Growth 2015-2018E, in Volume
Figure Europe Crohn s Disease Drug Market Size and Growth 2015-2018E, in USD Million
Figure Europe Crohn s Disease Drug Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Crohn s Disease Drug Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Crohn s Disease Drug Market Size and Growth 2015-2018E, in Volume
Figure South America Crohn s Disease Drug Market Size and Growth 2015-2018E, in USD Million
Figure South America Crohn s Disease Drug Market Size and Growth 2015-2018E, in Volume
Figure Middle East Crohn s Disease Drug Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Crohn s Disease Drug Market Size and Growth 2015-2018E, in Volume
Figure Africa Crohn s Disease Drug Market Size and Growth 2015-2018E, in USD Million
Figure Africa Crohn s Disease Drug Market Size and Growth 2015-2018E, in Volume
Figure Global Crohn s Disease Drug Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Crohn s Disease Drug Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Crohn s Disease Drug Sales Price Forecast 2019F-2025F
Figure Global Crohn s Disease Drug Gross Margin Forecast 2019F-2025F
Figure Global Crohn s Disease Drug Sales Revenue by Company in 2018, in USD Million
Figure Global Crohn s Disease Drug Price by Company in 2018
Figure Global Crohn s Disease Drug Gross Margin by Company in 2018